The Motley FoolAug 29, 3:15 PM ETNeutral
OmniAb is mentioned only as a recent collaboration partner with Eli Lilly with no analysis of its independent business merits or outlook.
OmniAb news
$4.740.00%
Close Sep 29, 2026 · split-adjustedArticles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0
About OmniAb
No recent articles focused on OmniAb.
Also mentions OABI
Articles that tag OABI but are mainly about other companies.
GlobeNewswire Inc.Jul 6, 7:00 AM ETNeutral
OmniAb is mentioned only as a strategic partner in a bispecific ADC program with no additional details provided about the partnership status, progress, or impact.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology